Abstract
HTRS2023.P2.9 Fitusiran prophylaxis demonstrates sustained bleed protection in people with hemophilia A or B: an exploratory analysis of antithrombin levels and peak thrombin generation from three phase 3 trials
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have